Page 11234..10..»

Archive for the ‘Stem Cell Complications’ Category

Omeros Reports Positive Data Across Primary and Secondary Endpoints in Pivotal Trial of Hematopoietic Stem Cell Transplant-Associated Thrombotic…

Wednesday, December 4th, 2019

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced positive data from its pivotal clinical trial of the companys novel investigational complement inhibitor narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a frequently lethal complication of HSCT. These preliminary data were recently provided to FDA as part of the companys ongoing interactions with the Agency on the narsoplimab Biologics License Application (BLA)

Read More...

Hunter Syndrome Treatment Market Size, Share & Trend Analysis By Treatment, By Region And Segment Forecasts, 2019 – 2026 – P&T Community

Wednesday, December 4th, 2019

NEW YORK, Dec.

Read More...

Herpes Virus Linked to Multiple Sclerosis – PrecisionVaccinations

Wednesday, December 4th, 2019

Researchers at Karolinska Institutet have developed a new method to separate different types of a common herpes virus (HHV-6) that has been linked to multiple sclerosis (MS). By analyzing antibodies in the blood against the most divergent proteins of herpesvirus 6A and 6B, these researchers were able to show that MS-patients carry the herpesvirus 6A to a greater extent than healthy individuals. This is relevant news since as many as 80 percent of all children are infected with the HHV-6 virus before 2 years of age

Read More...

Upstate SC toddler survives rare cancer and the risky procedure used to treat it – Greenville News

Tuesday, December 3rd, 2019

Outcome means a special Thanksgiving Hailie and Treylin Hyman saw the bruising on their baby girls leg as a sign that the active 1-year-old was learning to walk. But as a blood test would later reveal, little Maci was actually suffering from an extremely rare blood cancer that threatened her life without a risky treatment - atreatmentalmost as dangerous as the disease.

Read More...

Dr Sister Ltd Offers Effective Skin Treatments to Both Men and Women – The News Front

Tuesday, December 3rd, 2019

Dr Sister Ltd continues to offer effective skin treatments to both men and women, and they have been doing this for over 45 years now. Doctor Sister provides a comprehensive portfolio of treatments while at the same time delivering natural-looking, regenerative and enhancing results for the face and body

Read More...

Transplant Diagnostics Market to Witness Heightened Revenue Growth During the Forecast Period (2015-2021) – Statsflash

Tuesday, December 3rd, 2019

A research report on Transplant Diagnostics Market by Persistence Market Research features an in-depth analysis on the latest market trends. The report also includes detailed abstracts about statistics, revenue forecasts and market valuation. The report also offers a detailed analysis on the competitive landscape of the market.

Read More...

South Carolina toddler survives rare cancer and the risky procedure used to treat it – USA TODAY

Thursday, November 28th, 2019

Hailie Hyman holds her daughter Maci, 1, before an appointment at the Prisma Health Pediatric Hematology Oncology Center Monday, Nov.

Read More...

Sickle Cell Disease: Current Treatment and Emerging Therapies – AJMC.com Managed Markets Network

Thursday, November 28th, 2019

Lynne D.

Read More...

Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference – The Conversation US

Thursday, November 28th, 2019

What if someone told you that theres a disease you could catch where you couldnt feel any symptoms coming on?

Read More...

Autologous Stem Cell and Non-Stem Cell Based Therapies Market to Observe Strong Development by 2023 – Montana Ledger

Thursday, November 28th, 2019

In autologous stem cell and non-stem cell based therapies, an individuals cell is cultured and then re-introduced to the donors body. Used for the treatment of various bone marrow diseases, autologous stem cell and non-stem cell based therapies allows patients to have normal bone marrow, which gets destroyed in chemotherapy

Read More...

FDA-approved drug to prevent organ rejection may slow skin aging – News-Medical.net

Thursday, November 28th, 2019

The search for youthfulness typically turns to lotions, supplements, serums and diets, but there may soon be a new option joining the fray. Rapamycin, a FDA-approved drug normally used to prevent organ rejection after transplant surgery, may also slow aging in human skin, according to a study from Drexel University College of Medicine researchers published in Geroscience.

Read More...

Thankful People — ‘He’s gonna owe me big’: Matthew McKee receives bone-marrow donation from twin sister Allee – Southeast Missourian

Thursday, November 28th, 2019

In late October, laughter permeated The Olson Family Garden at St. Louis Childrens Hospital as Matthew McKee got the chance to do something abnormal: run and play outside

Read More...

Merck’s KEYTRUDA (pembrolizumab) Now Approved in China for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) in…

Thursday, November 28th, 2019

As you were browsing http://www.streetinsider.com something about your browser made us think you were a bot. If you are interested in http://www.streetinsider.com content, APIs are available. Please contact us here http://www.streetinsider.com/signup_content.php After completing the CAPTCHA below, you will immediately regain access to http://www.streetinsider.com.

Read More...

Global Blood Therapeutics: Oxbryta Is Finally Approved – Seeking Alpha

Thursday, November 28th, 2019

Global Blood Therapeutics, Inc. (GBT) confirmed that the FDA has approved Oxbryta (voxelotor) tablets for the treatment of sickle cell disease in adults and children 12 years of age and older

Read More...

Autologous Stem Cell and Non Stem Cell Based Therapies Market Shares, Strategies, and Forecasts Analysis – Downey Magazine

Friday, November 22nd, 2019

In autologous stem cell and non-stem cell based therapies, an individuals cell is cultured and then re-introduced to the donors body. Used for the treatment of various bone marrow diseases, autologous stem cell and non-stem cell based therapies allows patients to have normal bone marrow, which gets destroyed in chemotherapy. The various diseases that can be treated with the help of autologous stem cell and non-stem cell based therapies include: multiple myeloma, aplastic anemia, non-Hodgkins lymphoma, Parkinsons disease, Hodgkins lymphoma, thalassemia, and diabetes.

Read More...

Enlivex Therapeutics Ltd. (ENLV) Reports Complete Recruitment in Ph. Ib Trial Evaluating Safety & Efficacy of Universal Off-The-Shelf Allocetra in…

Wednesday, November 20th, 2019

As you were browsing http://www.streetinsider.com something about your browser made us think you were a bot. If you are interested in http://www.streetinsider.com content, APIs are available.

Read More...

Bone marrow transplant: What it is, uses, risks, and recovery – Medical News Today

Tuesday, November 19th, 2019

Bone marrow is soft, spongy tissue within some bones, including those in the hips and thighs. People with certain blood-related conditions benefit from a transplant that replaces damaged cells with healthy cells, possibly from a donor

Read More...

Enlivex Therapeutics Completes Recruitment In Phase Ib Trial Evaluating Safety And Efficacy Of Universal Off-The-Shelf Allocetra In Patients With…

Tuesday, November 19th, 2019

Nes Ziona, Israel, Nov.

Read More...

These Scientists May Have Found a Cure for ‘Bubble Boy’ Disease – Smithsonian.com

Tuesday, November 19th, 2019

On the morning of April 25, 2018, in Fort Wayne, Indiana, Omarion Jordan came into the world ten-fingers-and-toes perfect. His mother, Kristin Simpson, brought her dark-haired newborn home to a mostly empty apartment in Kendallville, about 30 miles to the north

Read More...

Linked-Up Molecules Through the Years – Science Magazine

Tuesday, November 19th, 2019

Were seeing a lot of bivalent molecules in drug discovery these days, especially with the popularity of bifunctional protein degrader ligands.

Read More...

Page 11234..10..»


2019 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick